Tested Applications
| Positive WB detected in | mouse liver tissue, rat liver tissue |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:1000-1:4000 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
24526-1-AP targets TRIM40 in WB, IF, IP, ELISA applications and shows reactivity with mouse, rat samples.
| Tested Reactivity | mouse, rat |
| Cited Reactivity | mouse, rat |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag21649 Product name: Recombinant human TRIM40 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-258 aa of BC060785 Sequence: MIPLQKDNQEEGVCPICQESLKEAVSTNCGHLFCRVCLTQHVEKASASGVFCCPLCRKPCSEEVLGTGYICPNHQKRVCRFCEESRLLLCVECLVSPEHMSHHELTIENALSHYKERLNRRSRKLRKDIAELQRLKAQQEKKLQALQFQVDHGNHRLEAGPESQHQTREQLGALPQQWLGQLEHMPAEAARILDISRAVTQLRSLVIDLERTAKELDTNTLKNAGDLLNRSAPQKLEVIYPQLEKGVSELLLQPPQKL Predict reactive species |
| Full Name | tripartite motif-containing 40 |
| Calculated Molecular Weight | 258 aa, 29 kDa |
| Observed Molecular Weight | 29-35 kDa |
| GenBank Accession Number | BC060785 |
| Gene Symbol | TRIM40 |
| Gene ID (NCBI) | 135644 |
| RRID | AB_3669440 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q6P9F5 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| WB protocol for TRIM40 antibody 24526-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The TRIM40 Polyclonal antibody (Cat# 24526-1-AP) has 1 citation to date. It was cited in Advanced Science (Impact Factor 14.1) in a 2026 study investigating TRIM40's role in driving pathological cardiac hypertrophy and heart failure through ubiquitination of PKN2. The antibody was validated in mouse and rat using WB, IP, and IF applications, placing the citation within the cardiovascular disease and protein modification research fields.
| Species | Application | Title |
|---|---|---|
Adv Sci (Weinh) TRIM40 Drives Pathological Cardiac Hypertrophy and Heart Failure via Ubiquitination of PKN2. |

